MetaCap

Fulgent Genetics Statistics

NASDAQ: FLGTHealth CareMedical SpecialitiesUSD

24.12-0.66 (-2.66%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Fulgent Genetics by the numbers

Fulgent Genetics has a market capitalization of $673.9 million based on 27.94M shares outstanding. With trailing EPS of $-3.10, Fulgent Genetics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.5% above its 50-day average and 26.2% above its 200-day average.

Average daily trading volume is 330.28K shares, or about $8.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

FLGT valuation vs. peer median

FLGT compared with the median of 8 peer companies
MetricFLGTPeer medianDifference
Market cap$673.89M$141.39M+377%
Avg. volume330.28K312.33K+6%

Peer median across 8 companies: YDES, CSTL, FRNM, TLSI, BNR, KEQU, XGN, BDSX.

Valuation

Market cap
$673.89M
Price / sales (latest FY)
2.09
EPS (TTM)
$-3.10

Price and trading

Previous close
24.78
Open
24.12
Day range
23.88 – 24.79
52-week range
13.46 – 31.04
52-week change
-19.60%
Beta
—
Volume
322.97K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
673.89M
Forward Pe
-17.74
Eps
-3.10
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
31.04
Week52 Low
13.46
Avg Volume
330.28K
Shares Outstanding
27.94M
Ma50
21.82
Ma200
19.11
Earnings Date
Nov 5, 2026
Pct From52w High
-22.29%
Pct From52w Low
79.20%

Related